Nascent Biotech, Inc. (NBIO)

Nascent Biotech Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	0.37	0.17	0.09	0	0
Cash & Cash Equivalents	0.37	0.17	0.09	0	0
Cash Growth	116.12%	82.37%	6479.37%	-55.41%	-97.55%
Receivables	0	0	0	0.75	0
Other Current Assets	0.18	0.08	0.01	0	0
Total Current Assets	0.55	0.26	0.11	0.75	0
Total Assets	0.55	0.26	0.11	0.75	0
Accounts Payable	0	0.5	0.78	0.64	0.85
Deferred Revenue	0	0	0	0.12	1.28
Current Debt	0	0.39	0	0.16	0.14
Other Current Liabilities	0.81	0.66	0	0.3	0.6
Total Current Liabilities	0.81	1.55	0.78	1.22	2.88
Other Long-Term Liabilities	0	0	0.78	0	0
Total Long-Term Liabilities	0	0	0.78	0	0
Total Liabilities	0.81	1.55	0.78	1.22	2.88
Total Debt	0	0.39	0	0.16	0.14
Debt Growth	-	-	-	16.51%	-
Common Stock	0.17	0.13	0.11	0.1	0.04
Retained Earnings	-24.26	-21.62	-18.82	-18.35	-16.84
Comprehensive Income	0	0	-0	0	0
Shareholders' Equity	-0.26	-1.3	-0.67	-0.47	-2.88
Total Liabilities and Equity	0.55	0.26	0.11	0.75	0
Net Cash / Debt	0.37	-0.22	0.09	-0.16	-0.14
Net Cash Per Share	0.00	-0.00	0.00	-0.00	-0.00
Working Capital	-0.26	-1.3	-0.67	-0.47	-2.88
Book Value Per Share	-0.00	-0.01	-0.01	-0.01	-0.08

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.